MX9800891A - Mocarhagina, una proteasa del veneno de cobra y usso terapeuticos de la misma. - Google Patents

Mocarhagina, una proteasa del veneno de cobra y usso terapeuticos de la misma.

Info

Publication number
MX9800891A
MX9800891A MX9800891A MX9800891A MX9800891A MX 9800891 A MX9800891 A MX 9800891A MX 9800891 A MX9800891 A MX 9800891A MX 9800891 A MX9800891 A MX 9800891A MX 9800891 A MX9800891 A MX 9800891A
Authority
MX
Mexico
Prior art keywords
mocarhagin
therapeutic uses
cobra venom
venom protease
protease
Prior art date
Application number
MX9800891A
Other languages
English (en)
Other versions
MXPA98000891A (es
Inventor
Michael C Berndt
Lindsay Dunlop
Robert Andrews
Mariagrazia Deluca
Original Assignee
Michael C Berndt
Lindsay Dunlop
Robert Andrews
Mariagrazia Deluca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael C Berndt, Lindsay Dunlop, Robert Andrews, Mariagrazia Deluca filed Critical Michael C Berndt
Publication of MX9800891A publication Critical patent/MX9800891A/es
Publication of MXPA98000891A publication Critical patent/MXPA98000891A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe la mocarhagina, una proteasa del veneno de cobra. También se proporcionan composiciones farmacéuticas y usos terapéuticos de la proteasa.
MXPA/A/1998/000891A 1995-08-01 1998-01-30 Mocarhagina, una proteasa del veneno de cobra y usos terapeuticos de la misma MXPA98000891A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/520,977 US5659018A (en) 1995-08-01 1995-08-01 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
US08520977 1995-08-01

Publications (2)

Publication Number Publication Date
MX9800891A true MX9800891A (es) 1998-10-31
MXPA98000891A MXPA98000891A (es) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
EP0842269A1 (en) 1998-05-20
AU711586B2 (en) 1999-10-14
AU6467696A (en) 1997-02-26
CA2227972A1 (en) 1997-02-13
US5659018A (en) 1997-08-19
WO1997005244A1 (en) 1997-02-13
EP0842269A4 (en) 1998-11-11
JPH11510682A (ja) 1999-09-21

Similar Documents

Publication Publication Date Title
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
ZA9710796B (en) Oxyiminopregnanecarbolactones.
WO1998046771A3 (en) Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
BG104117A (en) Universally applicable blood plasma
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
IL114331A0 (en) Medical use of bromelain
AU6467696A (en) Mocarhagin, a cobra venom protease, and therapeutic uses thereof
AU6633596A (en) Improved therapeutic agents
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
BG101605A (en) Enterokinetic benzamide
FI956178A0 (fi) Varsibromelaiiniproteaasin lääkekäyttö
BG104707A (en) Caspase-8 interacting proteins
AU1181897A (en) Medical use of proteases
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU1712395A (en) Medical application of bromelain
AU6206486A (en) P-acylaminobenzamides
AU5994796A (en) Modified kojibiosides analogues
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
AU5994696A (en) Modified alpha-d-glcp-(1-2)-alpha-d-glcp-(1-3)-alpha-d-glcp- analogues
AU8819691A (en) Treatment of gas
GB9616549D0 (en) Therapeutic product and its use
EP0957110A3 (en) Lyophilized tubulins
AU4398397A (en) Microorganism of the genus (ascochyta) and use thereof

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees